155 related articles for article (PubMed ID: 22820131)
1. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
de Pagter AP; Boelens JJ; Scherrenburg J; Vroom-de Blank T; Tesselaar K; Nanlohy N; Sanders EA; Schuurman R; van Baarle D
Clin Immunol; 2012 Sep; 144(3):179-89. PubMed ID: 22820131
[TBL] [Abstract][Full Text] [Related]
2. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
3. Increased proportion of perforin-expressing CD8+T-cells indicates control of herpesvirus reactivation in children after stem cell transplantation.
de Pagter PJ; Boelens JJ; Jacobi R; Schuurman R; Nanlohy NM; Sanders EA; van Baarle D
Clin Immunol; 2013 Jul; 148(1):92-8. PubMed ID: 23669455
[TBL] [Abstract][Full Text] [Related]
4. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.
de Pagter PJ; Schuurman R; Keukens L; Schutten M; Cornelissen JJ; van Baarle D; Fries E; Sanders EA; Minnema MC; van der Holt BR; Meijer E; Boelens JJ
Bone Marrow Transplant; 2013 Nov; 48(11):1460-4. PubMed ID: 23771003
[TBL] [Abstract][Full Text] [Related]
5. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients.
Fujita A; Ihira M; Suzuki R; Enomoto Y; Sugiyama H; Sugata K; Suga S; Asano Y; Yagasaki H; Kojima S; Matsumoto K; Kato K; Yoshikawa T
J Infect; 2008 Sep; 57(3):241-8. PubMed ID: 18662831
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children.
Caserta MT; McDermott MP; Dewhurst S; Schnabel K; Carnahan JA; Gilbert L; Lathan G; Lofthus GK; Hall CB
J Pediatr; 2004 Oct; 145(4):478-84. PubMed ID: 15480370
[TBL] [Abstract][Full Text] [Related]
11. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
12. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
[TBL] [Abstract][Full Text] [Related]
13. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
14. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
[TBL] [Abstract][Full Text] [Related]
17. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
18. Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation.
Guérin-El Khourouj V; Dalle JH; Pédron B; Yakouben K; Bensoussan D; Cordeiro DJ; Peltier L; Ouachée-Chardin M; Baruchel A; Sterkers G
Biol Blood Marrow Transplant; 2011 Apr; 17(4):476-85. PubMed ID: 20869455
[TBL] [Abstract][Full Text] [Related]
19. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT.
Król L; Stuchlý J; Hubáček P; Keslová P; Sedláček P; Starý J; Hrušák O; Kalina T
Bone Marrow Transplant; 2011 Aug; 46(8):1089-98. PubMed ID: 21057553
[TBL] [Abstract][Full Text] [Related]
20. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation.
Mori Y; Miyamoto T; Nagafuji K; Kamezaki K; Yamamoto A; Saito N; Kato K; Takenaka K; Iwasaki H; Harada N; Abe Y; Teshima T; Akashi K
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1596-602. PubMed ID: 20685258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
